September 2, 2025 – Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) announced that it has begun U.S. commercialization of TEPADINA® (thiotepa) for Injection 200 mg in a patented multichambered bag…
September 2, 2025 – Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) announced that it has begun U.S. commercialization of TEPADINA® (thiotepa) for Injection 200 mg in a patented multichambered bag…